As an expert for innovation, CEO Jost is invited to comment on a draft bill of the Green Party about a research bonus for SME.

DexLeChem already invests the majority of its expenditures in the development of new, disruptive products and services. Laying the foundation for the chemical production of the future, DexLeChem is considered as best practice in industry. As a service provider, the company is also receiving daily insights about what kind of barriers hinder companies to develop and implement more highly innovative technologies. On February, 26 CEO Jost reports as an expert at the German Bundestag how tax incentives for research should be designed to increase investment in the future and thus competitiveness in SME.

About the event:

During the expert consultation, the Green Party presents a draft bill about a SME Research Promotion Act to invited experts. The aim is to debate whether the suggestions are practical and useful to increase higher innovation activity in small and medium-sized enterprises and in Germany as a whole.